The therapy, also known as UM171 Cell Therapy, recently received conditional marketing authorization from the European Commission
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
First research project, supported by the Gates Foundation, focuses on developing non-hormonal contraceptives for women in low- and middle-income countries
Merck KGaA, Darmstadt, Germany announced the presentation of new oncology data across more than 12 tumor types at ASCO 2025
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Company is investing more than €100 million in the expansion of the Halle site
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Both companies have been selected for stand-by production by German government
Subscribe To Our Newsletter & Stay Updated
